Videos

Professor Dr. Brenda Penninx discusses the heterogeneity of major depressive disorder, with specific reference to immunometabolic depression

Professor Dr. Per Borghammer unpacks the brain-first vs body-first model of Parkinson’s disease, exploring distinct pathways of progression from the gut or nose and their potential to drive personalized medicine and innovative treatments.

Discover how human models of migraine have identified key molecular triggers like CGRP and PACAP, revolutionizing treatment options and offering hope for patients unresponsive to current therapies.

In this video, Professor Christoph Correll, Chair of the Neurotorium Editorial Board, introduces Neurotorium.

Professors Shen-Yang Lim and Christoph Correll explore dopamine’s role in Parkinson’s disease and schizophrenia, discussing treatment evolution, side effects, and parallels between the disorders. Access more resources at Neurotorium.org.

Professors Christoph Correll and Gabriele Fischer discuss the challenges of managing co-occurring schizophrenia and substance use disorders, offering insights into this complex comorbidity.